Dr. Thomas Oates, MD (he/him) is an Endocrinologist in Lakeland, FL with over 16 years of experience. What is your opinion of Dr. Thomas Oates, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Thomas Oates, MD has received over $948,092 which includes payments from the following companies:
$346,749.36 from Amgen Inc.
$224,356.44 from Janssen Pharmaceuticals, Inc
$158,517.17 from LILLY USA, LLC
$69,066.67 from Novo Nordisk Inc
$58,458.02 from sanofi-aventis U.S. LLC
$34,057.50 from AstraZeneca Pharmaceuticals LP
$23,382.96 from Boehringer Ingelheim Pharmaceuticals, Inc.
$19,204.77 from GlaxoSmithKline, LLC.
$11,691.89 from AbbVie, Inc.
$259.48 from Shire North American Group Inc
$256.90 from Merck Sharp & Dohme Corporation
$228.39 from MannKind Corporation
$205.56 from Takeda Pharmaceuticals America, Inc.
$198.74 from Abbott Laboratories
$139.57 from Dexcom, Inc.
$138.75 from Eisai Inc.
$134.31 from Regeneron Healthcare Solutions, Inc.
$86.08 from Radius Health, Inc.
$84.51 from Amarin Pharma Inc.
$82.07 from Aegerion Pharmaceuticals, Inc.
Payments received by Dr. Thomas Oates, MD were from the following categories:
$791,711.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!